Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Higashio

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Biochemical and Biophysical Research Communications|June 4, 1998
Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of boneK Tsukii, N Shima, S Mochizuki, et al.
Biochemical and Biophysical Research Communications|November 5, 1999
Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cellsN Nakagawa, H Yasuda, K Yano, et al.
Bone|December 17, 1998
Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancyT Akatsu, T Murakami, K Ono, et al.
Endocrinology|August 31, 2000
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and functionN Udagawa, N Takahashi, H Yasuda, et al.
Biochemical and Biophysical Research Communications|October 1, 1998
Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclastT Akatsu, T Murakami, M Nishikawa, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actionsJ M Quinn, K Itoh, N Udagawa, et al.
The Journal of Biological Chemistry|March 30, 2001
Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontinH Ihara, D T Denhardt, K Furuya, et al.
Bone|July 28, 1999
A novel molecular mechanism modulating osteoclast differentiation and functionH Yasuda, N Shima, N Nakagawa, et al.
Endocrinology|July 19, 2001
Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligandK Itoh, N Udagawa, T Katagiri, et al.
Bone|November 26, 1999
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligandN Udagawa, N Takahashi, E Jimi, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Biochemical and Biophysical Research Communications|June 4, 1998
Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of boneK Tsukii, N Shima, S Mochizuki, et al.
Biochemical and Biophysical Research Communications|November 5, 1999
Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cellsN Nakagawa, H Yasuda, K Yano, et al.
Bone|December 17, 1998
Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancyT Akatsu, T Murakami, K Ono, et al.
Endocrinology|August 31, 2000
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and functionN Udagawa, N Takahashi, H Yasuda, et al.
Biochemical and Biophysical Research Communications|October 1, 1998
Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclastT Akatsu, T Murakami, M Nishikawa, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actionsJ M Quinn, K Itoh, N Udagawa, et al.
The Journal of Biological Chemistry|March 30, 2001
Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontinH Ihara, D T Denhardt, K Furuya, et al.
Bone|July 28, 1999
A novel molecular mechanism modulating osteoclast differentiation and functionH Yasuda, N Shima, N Nakagawa, et al.
Endocrinology|July 19, 2001
Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligandK Itoh, N Udagawa, T Katagiri, et al.
Bone|November 26, 1999
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligandN Udagawa, N Takahashi, E Jimi, et al.
Pageof 7